Polyethylene glycol treated human normal immunoglobulin (Mitsubishi Tanabe/Japan blood products organisation)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePolyethylene glycol treated human normal immunoglobulin (Mitsubishi Tanabe/Japan blood products organisation)
Drug Alias Name聚乙二醇处理的人免疫球蛋白Venoglobulin-IHImmunoglobulin G pegylatedKenketsu Venoglobulin-IHKenketsu Venoglobulin IH +[7] 
ClassificationBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPemphigoid, BullousScleroderma, SystemicAgammaglobulinemia +[15] 
Global Approved IndicationsPemphigoid, BullousAgammaglobulinemiaPurpura, Thrombocytopenic, Idiopathic +[12] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1991/06/28
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMitsubishi Tanabe Pharma
China Registration ClassN/A

Develop Information

Active CompaniesJapan Blood Products Organization
Inactive CompaniesBenesis Corporation
Active IndicationsPemphigoid, BullousAgammaglobulinemiaPurpura, Thrombocytopenic, Idiopathic +[12] 
Inactive IndicationsScleroderma, SystemicAbortion, HabitualKidney Failure, Chronic

Other Information

ATC CodeJ06BA
Related LinksN/A